Single agent cephalosporin prophylaxis for penetrating abdominal trauma. Results and comment on the emergence of the enterococcus. 1986

D V Feliciano, and L O Gentry, and C G Bitondo, and J M Burch, and K L Mattox, and P A Cruse, and G L Jordan

Multiple studies have shown that the incidence of infectious complications after penetrating abdominal wounds are decreased by the perioperative administration of antibiotics. In this study of three separate single cephalosporin agents (cefotaxime, cefoxitin, and moxalactam) given for a 48 hour period in patients who sustained perforating gastrointestinal wounds, uncomplicated recoveries occurred in 93 percent of all patients. The rates of uncomplicated recovery were significantly different for the three groups; however, patients with major intraabdominal vascular injuries were more common in the cefoxitin-treated group. One disturbing feature was the presence of enterococci in 57 percent of isolates from wound infections and 60 percent of isolates from intraabdominal abscesses. Enterococci as sole isolates were found in one of two wound infections and three of four intraabdominal abscesses in the moxalactam-treated group.

UI MeSH Term Description Entries
D008297 Male Males
D009070 Moxalactam Broad- spectrum beta-lactam antibiotic similar in structure to the CEPHALOSPORINS except for the substitution of an oxaazabicyclo moiety for the thiaazabicyclo moiety of certain CEPHALOSPORINS. It has been proposed especially for the meningitides because it passes the blood-brain barrier and for anaerobic infections. 1-Oxacephalosporin,6059-S,Disodium Latamoxef,Disodium Moxalactam,Festamoxin,Lamoxactam,Latamoxef,Lilly 127935,Ly-127935,Ly127935,Moxalactam Disodium,S-6059,Shiomarin,1 Oxacephalosporin,6059 S,6059S,Disodium, Moxalactam,Latamoxef, Disodium,Ly 127935,Moxalactam, Disodium,S 6059,S6059
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002439 Cefotaxime Semisynthetic broad-spectrum cephalosporin. Benaxima,Biosint,Cefotaxim,Cefotaxime Sodium,Cefradil,Cephotaxim,Claforan,Fotexina,HR-756,Kendrick,Klaforan,Primafen,Ru-24756,Taporin,HR 756,HR756,Ru 24756,Ru24756,Sodium, Cefotaxime
D002440 Cefoxitin A semisynthetic cephamycin antibiotic resistant to beta-lactamase. Cefoxitin Sodium,MK-306,Mefoxin,Mefoxitin,Méfoxin,MK 306,MK306,Sodium, Cefoxitin
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D V Feliciano, and L O Gentry, and C G Bitondo, and J M Burch, and K L Mattox, and P A Cruse, and G L Jordan
January 1989, Diagnostic microbiology and infectious disease,
D V Feliciano, and L O Gentry, and C G Bitondo, and J M Burch, and K L Mattox, and P A Cruse, and G L Jordan
January 1988, Drugs,
D V Feliciano, and L O Gentry, and C G Bitondo, and J M Burch, and K L Mattox, and P A Cruse, and G L Jordan
February 1986, Archives of surgery (Chicago, Ill. : 1960),
D V Feliciano, and L O Gentry, and C G Bitondo, and J M Burch, and K L Mattox, and P A Cruse, and G L Jordan
February 1985, The New England journal of medicine,
D V Feliciano, and L O Gentry, and C G Bitondo, and J M Burch, and K L Mattox, and P A Cruse, and G L Jordan
January 1982, Clinical therapeutics,
D V Feliciano, and L O Gentry, and C G Bitondo, and J M Burch, and K L Mattox, and P A Cruse, and G L Jordan
January 1991, Reviews of infectious diseases,
D V Feliciano, and L O Gentry, and C G Bitondo, and J M Burch, and K L Mattox, and P A Cruse, and G L Jordan
September 2021, AJR. American journal of roentgenology,
D V Feliciano, and L O Gentry, and C G Bitondo, and J M Burch, and K L Mattox, and P A Cruse, and G L Jordan
January 1994, Scandinavian journal of infectious diseases. Supplementum,
D V Feliciano, and L O Gentry, and C G Bitondo, and J M Burch, and K L Mattox, and P A Cruse, and G L Jordan
December 2019, The Cochrane database of systematic reviews,
D V Feliciano, and L O Gentry, and C G Bitondo, and J M Burch, and K L Mattox, and P A Cruse, and G L Jordan
June 2015, World journal of surgery,
Copied contents to your clipboard!